<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Chan FT</submitter><funding>Medical Research Council</funding><funding>Alzheimers Research UK</funding><funding>Wellcome Trust</funding><funding>Biotechnology and Biological Sciences Research Council</funding><funding>Engineering and Physical Sciences Research Council</funding><pagination>2156-62</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC5360231</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>138(7)</volume><pubmed_abstract>We report observations of an intrinsic fluorescence in the visible range, which develops during the aggregation of a range of polypeptides, including the disease-related human peptides amyloid-β(1-40) and (1-42), lysozyme and tau. Characteristic fluorescence properties such as the emission lifetime and spectra were determined experimentally. This intrinsic fluorescence is independent of the presence of aromatic side-chain residues within the polypeptide structure. Rather, it appears to result from electronic levels that become available when the polypeptide chain folds into a cross-β sheet scaffold similar to what has been reported to take place in crystals. We use these findings to quantify protein aggregation in vitro by fluorescence imaging in a label-free manner.</pubmed_abstract><journal>The Analyst</journal><pubmed_title>Protein amyloids develop an intrinsic fluorescence signature during aggregation.</pubmed_title><pmcid>PMC5360231</pmcid><funding_grant_id>EP/H018301/1</funding_grant_id><funding_grant_id>089703</funding_grant_id><funding_grant_id>ARUK-EG2012A-1</funding_grant_id><funding_grant_id>BB/E019927/1</funding_grant_id><funding_grant_id>MC_G1000734</funding_grant_id><pubmed_authors>Bertoncini CW</pubmed_authors><pubmed_authors>Dobson CM</pubmed_authors><pubmed_authors>Kaminski Schierle GS</pubmed_authors><pubmed_authors>Kumita JR</pubmed_authors><pubmed_authors>Chan FT</pubmed_authors><pubmed_authors>Kaminski CF</pubmed_authors></additional><is_claimable>false</is_claimable><name>Protein amyloids develop an intrinsic fluorescence signature during aggregation.</name><description>We report observations of an intrinsic fluorescence in the visible range, which develops during the aggregation of a range of polypeptides, including the disease-related human peptides amyloid-β(1-40) and (1-42), lysozyme and tau. Characteristic fluorescence properties such as the emission lifetime and spectra were determined experimentally. This intrinsic fluorescence is independent of the presence of aromatic side-chain residues within the polypeptide structure. Rather, it appears to result from electronic levels that become available when the polypeptide chain folds into a cross-β sheet scaffold similar to what has been reported to take place in crystals. We use these findings to quantify protein aggregation in vitro by fluorescence imaging in a label-free manner.</description><dates><release>2013-01-01T00:00:00Z</release><publication>2013 Apr</publication><modification>2024-02-15T02:23:34.232Z</modification><creation>2019-03-27T02:39:10Z</creation></dates><accession>S-EPMC5360231</accession><cross_references><pubmed>23420088</pubmed><doi>10.1039/c3an36798c</doi></cross_references></HashMap>